Celestica (CLS) reachead $55.57 at the closing of the latest trading day, reflecting a -0.63% change compared to its last close.
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
DXPE, ENGIY, LXFR, YOU and CLS have been added to the Zacks Rank #1 (Strong Buy) List on May 29, 2023.
Finding high-growth investment opportunities in the middle of volatile markets is like finding gold. These days, three exceptional businesses have surfaced, all displaying eye-catching numbers and bright futures that attract the attention of astute investors throughout the globe.
Thanks to the promising demand commentaries from NVDA and SMCI, it is apparent that we are in the early innings of generative AI infrastructure boom. With continued demand strength for AI/ ML compute/networking products from hyperscaler customers, we can understand why CLS has raised their FY2024 guidance. Consensus forward estimates imply accelerated top/ bottom line growth as well, thanks to its manufacturing ramp up in Thailand/Malaysia and the shorter enterprise replacement cycle.
Celestica stock has continued to outperform the market. The leading EMS player is exposed to significant AI growth tailwinds from the leading cloud hyperscalers. Celestica's cautious guidance shouldn't be construed negatively, given its record of solid execution and outperformance.
Celestica's stock price has surged over 400% in the past year, even outperforming Nvidia. The company reported strong Q1 earnings, beating revenue and EPS expectations. Celestica's strategic focus on the AI custom compute market has positioned it as a key AI player, with the potential for continued growth and margin expansion.
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.
CLS, DXPE, FBP, RCMT and SIGA have been added to the Zacks Rank #1 (Strong Buy) List on May 17, 2024.
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Celestica (CLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.